Moderna’s COVID-19 Vaccine (mRNA-1273) Boosts Immune Response and Appears Safe in Older Adults in Phase 1 Study
Moderna, Inc.’s (Cambridge, MA, USA) COVID-19 vaccine (mRNA-1273) induced consistently high levels of pseudovirus neutralization antibody titers in all participants in the 56-70 and 71+ age groups in Phase 1 study. More...01 Oct 2020
Sorrento and ViralClear to Test Combination of Neutralizing Antibody and Oral Anti-Viral Compound Against COVID-19
Sorrento Therapeutics (San Diego, CA, USA) has entered into an agreement with ViralClear Pharmaceuticals, Inc. (Westport, CT, USA) to explore the synergistic potential of small molecules and antibodies combination therapies against COVID-19. More...01 Oct 2020
First Study Shows SARS-CoV-2 Induces Long-Lived Memory B Cells That May Provide Lifelong Immunity to COVID-19
New research suggests that past colds may provide some protection from the SARS-CoV-2 virus and that immunity to COVID-19 is likely to last a long time, maybe even a lifetime. More...30 Sep 2020
World’s First Face Mask Designed to Capture and Deactivate SARS-CoV-2 Could Lower COVID-19 Infection Rate
A novel face mask is designed to provide enhanced protection from infection by capturing the SARS-CoV-2 virus in the face mask filter layer before it reaches or after it exits the user's respiratory system. More...30 Sep 2020
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Plasma Freezer
iBF125-GX
New
Cannulating Sphincterotome
TRUEtome
In Other News
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk
150 Million Rapid COVID-19 Tests from Abbott Begin Rolling out Across US
FDA Grants First Ever EUA to COVID-19 POC Antibody Test for Use with Fingerstick Blood Samples
120 Million COVID-19 Rapid Tests to Be Made Available for Low and Middle Income Countries
Some COVID-19 Vaccines Could Work Better on One Patient Population than Others, Says Dr. Anthony Fauci
China Doses Thousands with Unproven COVID-19 Vaccines Having Potentially Harmful Side Effects
COVID-19 Saliva Tests Could Detect Silent Carriers
Hologic Granted FDA Emergency Use Authorization for Asymptomatic COVID-19 Testing with Panther Fusion SARS-CoV-2 Assay
New Preventative Nasal Spray Reduces Viral Replication by Up to 96% in COVID-19 Challenge Study
SARS-CoV-2 Viral Load Could Be Key to Recovery from COVID-19
COVID-19 Patients Having Sufficient Vitamin D Experience Reduced Complications and Lower Mortality
SARS-CoV-2 Mutations Having Higher Transmission Rates Could Require Yearly COVID-19 Vaccine Shots
Johnson & Johnson COVID-19 Vaccine Generates Strong Immune Response in Mid-Stage Trials
Dried Blood Spot Sampling Offers Inexpensive Way to Widen Access to COVID-19 Antibody Testing
Blood-Based Test That Accurately Identifies Viral Infection Before Symptoms Develop Could Help in Early Identification of SARS-CoV-2
New, Portable COVID-19 Saliva-Based Testing Device to Deliver Results in as Little as 20 Minutes
Cepheid Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV Granted FDA Emergency Use Authorization
Man's Best Friend: The Ultimate COVID-19 Screening Solution?
FDA Authorizes First Nanopore Sequencing-Based Test for SARS-CoV-2
Statins Reduce COVID-19 Severity by Removing Cholesterol Used by SARS-CoV-2 to Infect Cells
Researchers Predict Which Antibodies Provide Best Protection Against SARS-CoV-2 and Which COVID-19 Vaccines Might Help
Discovery of Highly Effective SARS-CoV-2 Antibodies to Aid Development of Passive Vaccination
New ABC Test for Influenza A, Influenza B, and COVID-19 to Be Launched in First Week of October
